Erchonia DPN Laser (Model# EVRL)
Erchonia Corporation · Decision date Feb 19, 2026
What did the FDA decide?
FDA records K251903 as a 510(k) premarket notification, with a decision dated Feb 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Feb 19, 2026
Regulatory record facts
- Identifier
- K251903
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Erchonia Corporation
- Product code
- NHN
- Decision code
- SESE
- Decision date
- Feb 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Light Based Laser Non-Thermal Instrument With Non-Heating Effect For Adjunctive Use In Pain Therapy.
- Applicant
- Erchonia Corporation
- Product code
- NHN
- FDA device class
- 2
FDA decision timeline
K251903 received
Application receipt date recorded by FDA.
K251903 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NHN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MR5 Activ ProK254024 | Multi Radiance Medical, Inc. | 510(k) clearance | May 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Erchonia Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Fountain Inn, SC
Sources and methodology
- Original FDA record: K251903
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records